IDSA : View All Statements on Antimicrobial Stewardship

03/15/2012

Antimicrobial Stewardship Policy Statement of the IDSA, SHEA and PIDS

IDSA, SHEA, PIDS, Infection Control and Hospital Epidemiology vol. 33 no. 4 March 15, 2012 322-327.

Joint position statement of IDSA, SHEA and PIDS outlining recommendations for the mandatory implementation of antimicrobial stewardship throughout health care, including recommendations to monitor interventions and methods to address current deficiencies in education and research, as well as the lack of accurate data on antimicrobial use in the United States.

06/09/2010

IDSA Testimony on Antibiotic Resistance, delivered before the House Energy and Commerce Health Subcommittee (PDF)

Brad Spellberg, MD, FIDSA, presented IDSA's statement at a hearing on “Promoting the Development of Antibiotics and Ensuring Judicious Use in Humans.”

02/06/2009

IDSA and SHEA Respond to Federal Action Plan on Healthcare-Associated Infections (PDF)

IDSA and SHEA urge increased funding, ongoing stakeholder input and development of an implementation portion of the plan in response to HHS' release of the draft "Action Plan to Prevent Healthcare-Associated Infections" in January 2009 following criticism of federal inaction.

01/01/2009

Bad Bugs, No Drugs, No ESKAPE: An Update on the State of the Pipeline (PDF)

Boucher et al., Clinical Infectious Diseases vol. 48 no. 1 January 1, 2009

IDSA expresses concern about the lean pipeline for novel therapeutics to treat drug-resistant infections, especially those caused by gram-negative pathogens.

06/18/2008

IDSA Preliminary Statement on Antibiotic Home Stockpiling

At a meeting of the National Biodefense Science Board (NBSB), IDSA delivered public comments raising concerns about an HHS initiative to inform the public about home stockpiling of doxycycline for use in a potential anthrax attack.

01/15/2008

The Epidemic of Antimicrobial Resistant Infections (PDF)

Spellberg et al., Clinical Infectious Diseases vol. 46 no. 2 January 15, 2008 155-164.

A call to action for the medical community from the Infectious Diseases Society of America.

04/24/2006

Principles and Strategies to Limit the Impact of Antimicrobial Resistance (PDF)

IDSA principles and strategies intended to limit the impact of antimicrobial resistance.

IDSA Testifies on Medical Countermeasures Enterprise Review (PDF)

09/29/2010

Dr. Andy Pavia testified on behalf of IDSA at a September 29, 2010 hearing of the Senate Labor-Health and Human Services-Education Appropriations Subcommittee examining the Public Health Emergency Medical Countermeasures Enterprise review recently completed by the HHS Secretary.

IDSA Testimony on Antimicrobial Resistance at FDA Part 15 Hearing (PDF)

04/28/2008

IDSA presented testimony to a US Food and Drug Administration (FDA) panel on April 28 to address the increasingly troublesome issue of antimicrobial resistance.